关键词:
  首页 > 美迪医讯 > Abbott公司即将研制先兆子痫检测方法  

Abbott公司即将研制先兆子痫检测方法

【 2005-08-04 发布 】 美迪医讯
美迪网领先的医疗器械电子商务平台

 

根据一项近期的协议,Abbott实验室获得了将Nephromics公司获得的的检测和监测先兆子痫的两种蛋白质,开发成商业化产品的全球准独家权利。,

Abbott打算开发成为检测先兆子痫的体外检测方法。目前对这种危及生命的疾病还没有特异性的诊断检测方法,这种疾病每年都危及许多妊娠妇女。Abbott实验室诊断测试与系统开发副总裁William Brow博士解释说:“Abbott的目标是开发分娩前检测方法,能够用于对妊娠并发症进行早期的危险分层检测。”

Abbott具有研发内分泌和其它激素相关检测方法的历史;向全球诊断检测市场的关键领域提供范围广泛的革新设备系统和检测方法。


“Because preeclampsia can strike quickly, potentially causing severe and immediate complications such as seizures and organ failure that threaten both the health of the baby and mother unless pregnancy is induced, early diagnostic tests are needed,” observed David Barch, M.D., medical director, Abbott Diagnostics. “These tests would be developed for use on our premier diagnostic analyzer, the Architect integrated immunoassay and clinical chemistry system.”
Abbott诊断公司的医学主任David Barch说:“因为先兆子痫起病迅速,能够导致严重的并发症,例如癫痫发作和器官功能衰竭,在妊娠没有开始之前就会危及婴儿和母亲的健康,因此早期诊断检测是十分必要的。这些即将研制的检测方法,将使用我们公司功能强大的诊断分析仪:Architect综合免疫分析和临床化学系统。”

Abbott to Develop Preeclampsia Test
 
Under a recent agreement, worldwide semi-exclusive rights to commercialize products using patents of Nephromics (Chestnut Hill, MA, USA) related to two proteins for detecting and monitoring preeclampsia have been granted to Abbott Laboratories (Abbott Park, IL, USA).

Abbott intends to develop an in vitro diagnostic test to detect preeclampsia. There is currently no specific diagnostic test for this life-threatening disease that affects many pregnant women each year. “Abbott’s goal is to develop prenatal tests that could be utilized for early risk stratification of pregnancy complications,” explained William Brown, Ph.D., vice president, diagnostic assays and systems development, Abbott Labs.

Abbott has a history of developing endocrine and other hormone-related tests and offers a broad range of innovative instrument systems and tests across key segments of the global diagnostics market. Immunodiagnostics is a core component of the company’s medical products business.

“Because preeclampsia can strike quickly, potentially causing severe and immediate complications such as seizures and organ failure that threaten both the health of the baby and mother unless pregnancy is induced, early diagnostic tests are needed,” observed David Barch, M.D., medical director, Abbott Diagnostics. “These tests would be developed for use on our premier diagnostic analyzer, the Architect integrated immunoassay and clinical chemistry system.”

/**/
本文关键字: Abbott公司,先兆子痫 
收藏本文到: Google书签 Digg Live Bookmark Yahoo书签 Facebook 百度搜藏 新浪ViVi 365Key网摘 天极网摘 和讯网摘 POCO网摘 QQ书签

  《美迪医讯》欢迎您参与新闻投稿,业务咨询: 美迪医疗网业务咨询

我要评论:《Abbott公司即将研制先兆子痫检测方法》
匿名发表 我的名字: Email: 验证码: 点击可刷新
 
    

  更多关于 Abbott公司,先兆子痫  的新闻

合作支持:中华医学会 | 中华医院管理学会 | 国家食品药品监督管理家用护理器械商城 | 国药励展展览有限责任公 | 医学装备协会
刊登广告 | 友情链接 | 广告代理商加盟 | 关于美迪 | 法律声明 | 隐私保护 | 网站地图
把美迪网放进收藏夹  把美迪医疗网介绍给我的朋友  给美迪医疗网留言
美迪医疗网广告业务联系:021-51601230 产品咨询业务联系:021-51601230 传真:021-56532303    美迪医疗网业务咨询
互联网药品信息服务许可证:(沪)-经营性-2009-0003   中华人民共和国电信与信息服务业务经营许可证:(沪)B2-20090029 沪ICP备14001091号-8
 
公安备案号 31010602000199 医疗器械经营许可证: 沪静药监械经营许20210003号 第二类医疗器械经营备案凭证: 沪静药监械经营备20220042号
营业执照:统一社会信用代码91310108676284138X互联网药品信息服务资格书:(沪)-非经营性-2023-0081
消防排烟风机 华创商务网
美迪医疗网广告业务联系:021-51601230  产品咨询业务联系:021-51601230 传真:021-56532303   美迪医疗网产品咨询 本QQ仅咨询广告和会员业务,不咨询产品和药品等业务美迪医疗网推广业务咨询